SCHEMBL31454837

SCHEMBL31454837

CCc1cc(=O)oc2c(C(=O)N3CCCc4ccccc43)c(O)ccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.63
▸ KDM4E B2RXH2 6/20 0.63
▸ MAPT P10636 5/20 0.63
▸ HPGD P15428 5/20 0.63
▸ GAA P10253 4/20 0.63
▸ LMNA P02545 3/20 0.63
▸ NPSR1 Q6W5P4 2/20 0.63
▸ HTT P42858 2/20 0.63
▸ CYP2C19 P33261 2/20 0.58
▸ TSHR P16473 5/20 0.57
▸ HSD17B10 Q99714 4/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ ALOX15 P16050 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ SPR P35270 1/20 0.49
▸ ATM Q13315 1/20 0.48
▸ ERAP1 Q9NZ08 1/20 0.48
▸ MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454892 0.93 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454869 0.92 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454962 0.91 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454961 0.91 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454838 0.88 CYP2C19 (0.69) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454924 0.88 ALDH1A1 (0.68) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454894 0.86 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454873 0.85 ALDH1A1 (0.67) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454890 0.85 ALDH1A1 (0.66) ALDH1A1KDM4EMAPTHPGDGAA
SCHEMBL31454916 0.83 CYP2C19 (0.51) ALDH1A1KDM4EMAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042896-A1 DNA TOPOISOMERASE IIβ INHIBITORS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2025-02-27 — — WO disclosed
Send feedback